PATENT CLAIM ANALYSIS

Application Number: 15928509
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
A pharmaceutical preparation and method for treating connective tissue damage in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of a glycosaminoglycan composition comprising chondroitin sulfate, hyaluronan, and N-acetyl D-glucosamine, wherein the connective tissue is skin.

Claim (Index 6):
The method of  claim 1 , wherein the composition is a sterile solution for administration or dispersed onto or within a deformable semi-solid or solid material adapted for administration onto an affected area of said connective tissue of a human or animal body.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13545327', '14941754', '14511274', '11766510', '13891979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8318097127391219
- 35 USC 102 Novelty (BERT): 0.5682457911883769
- Combined Prediction Score: 0.8054533205840473
- Mean Citation Score: 432.1815
- Max Citation Score: 451.97458
- Similarity Product: 406.97183198492286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test